glp-1/gip agonist New strategies for the treatment of obesity and metabolic dysfunctions Tirzepatide's Unique Mechanism of Action
Description
Semaglutide drugs have been shown to increase the risk of eye strokes that cause vision loss
Meal size and timing: Eating smaller, more frequent meals rather than two or three large meals reduces the GI discomfort that GLP-1 agonists can cause
MRV also showed mild narrowing in the lateral part of the right transverse sinus
Occurred in patients who received tirzepatide injection at least twice as often as in those who received placebo 2
It should be remembered that all patients having colonoscopy undertake a similar fluid/semi-solid diet with bowel prep solution for 24 hours prior to their procedure
